Leavitt Chase C. 4
4 · Oncternal Therapeutics, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Leavitt Chase C.
General Counsel/Secretary
Transactions
- Purchase
Common Stock
2023-04-12$0.29/sh+15,000$4,350→ 96,901 total - Purchase
Common Stock
2023-04-13$0.29/sh+10,000$2,900→ 106,901 total